Holdings
Pfizer Inc
As of Sep 30, 2026, Pfizer Inc reported 16 positions worth US$157M. Largest: Allogene Therapeutics, Inc., Arvinas, Inc. and Celcuity Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Allogene Therapeutics, Inc. | 22M | US$36.4M | no change | Sep 30, 2026 |
| Arvinas, Inc. | 3.46M | US$26.2M | no change | Sep 30, 2026 |
| Celcuity Inc. | 296K | US$23.5M | no change | Sep 30, 2026 |
| AgomAb Therapeutics NV | 2.15M | US$22.6M | new | Sep 30, 2026 |
| Pyxis Oncology, Inc. | 7.03M | US$20.1M | no change | Sep 30, 2026 |
| Biohaven Ltd. | 506K | US$6.57M | no change | Sep 30, 2026 |
| Caribou Biosciences, Inc. | 4.69M | US$5.82M | no change | Sep 30, 2026 |
| ORIC Pharmaceuticals, Inc. | 373K | US$4.91M | no change | Sep 30, 2026 |
| Cardiff Oncology, Inc. | 2.41M | US$2.99M | no change | Sep 30, 2026 |
| Spero Therapeutics, Inc. | 2.36M | US$2.91M | no change | Sep 30, 2026 |